← Leaderboards
Tejabhiram Yadavalli
University Of Illinois At Chicago
$1,210,082
Attributed
$1,210,082
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $413.3K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$1,210,082 · 1
By mechanism
R01$1,210,082 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Deepak Shukla$19,733,938
- Abhijit A Date$4,064,660
- Zhenjia Wang$3,819,055
- Bin He$6,999,248
- Sandeep Jain$16,705,715
Others in their field
Other Rising Stars on “Dermatitis”
- Ricardo Valladares · Siolta Therapeutics, Inc.$2,921,132
- Michelle E Conroy · Massachusetts General Hospital$1,621,770
- Rajan P. Kulkarni · Oregon Health & Science University$1,394,503
- Emily Gurnee · University Of Colorado Denver$1,104,973
- Andrea Barrio · Sloan-Kettering Inst Can Research$1,083,462
- Joshua D. Milner · Columbia University Health Sciences$1,050,236
Research focus
DermatitisAdrenal Cortex HormonesAdsorptionCyclosporineAnalogAnti-Inflammatory AgentsAntiinflammatory EffectAntimicrobialAffectAcyclovirAreaBacteriaBenzalkonium ChlorideBlindnessCarbonCellsCharacteristicsChildClinical EfficacyClinically RelevantCommon TreatmentAdolescentCorneaDesign
Grant awards (3)
DECON: A sustained topical delivery platform to treat ocular inflammation$398,369
R01 · FY2025 · EY · contact PI
DECON: A sustained topical delivery platform to treat ocular inflammation$398,369
R01 · FY2024 · EY · contact PI
DECON: A sustained topical delivery platform to treat ocular inflammation$413,344
R01 · FY2023 · EY · contact PI